Chase Investment Counsel’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $748K | Buy |
6,224
+1,456
| +31% | +$168K | 0.2% | 93 |
|
|
2025
Q4 | $501K | Sell |
4,768
-2,668
| -36% | -$250K | 0.14% | 97 |
|
|
2025
Q3 | $624K | Sell |
7,436
-1,390
| -16% | -$114K | 0.18% | 87 |
|
|
2025
Q2 | $698K | Hold |
8,826
| – | – | 0.22% | 76 |
|
|
2025
Q1 | $792K | Sell |
8,826
-25
| -0.3% | -$2.33K | 0.29% | 73 |
|
|
2024
Q4 | $880K | Sell |
8,851
-30
| -0.3% | -$3.09K | 0.28% | 77 |
|
|
2024
Q3 | $1.01M | Buy |
8,881
+221
| +3% | +$26.3K | 0.34% | 73 |
|
|
2024
Q2 | $1.07M | Buy |
8,660
+300
| +4% | +$38.6K | 0.38% | 65 |
|
|
2024
Q1 | $1.1M | Buy |
8,360
+259
| +3% | +$31.9K | 0.41% | 68 |
|
|
2023
Q4 | $883K | Sell |
8,101
-5,615
| -41% | -$583K | 0.39% | 69 |
|
|
2023
Q3 | $1.41M | Sell |
13,716
-2,946
| -18% | -$318K | 0.7% | 46 |
|
|
2023
Q2 | $1.92M | Buy |
16,662
+8,228
| +98% | +$934K | 0.97% | 46 |
|
|
2023
Q1 | $897K | Sell |
8,434
-275
| -3% | -$29.7K | 0.5% | 58 |
|
|
2022
Q4 | $966K | Buy |
8,709
+380
| +5% | +$38.8K | 0.59% | 53 |
|
|
2022
Q3 | $717K | Hold |
8,329
| – | – | 0.45% | 52 |
|
|
2022
Q2 | $759K | Buy |
8,329
+285
| +4% | +$25.3K | 0.41% | 58 |
|
|
2022
Q1 | $660K | Sell |
8,044
-80
| -1% | -$6.31K | 0.29% | 61 |
|
|
2021
Q4 | $622K | Buy |
8,124
+205
| +3% | +$16.3K | 0.25% | 64 |
|
|
2021
Q3 | $594K | Sell |
7,919
-9,385
| -54% | -$714K | 0.26% | 59 |
|
|
2021
Q2 | $1.34M | Sell |
17,304
-665
| -4% | -$49.5K | 0.56% | 52 |
|
|
2021
Q1 | $1.32M | Buy |
17,969
+105
| +0.6% | +$7.75K | 0.6% | 55 |
|
|
2020
Q4 | $1.39M | Sell |
17,864
-414
| -2% | -$31.7K | 0.61% | 51 |
|
|
2020
Q3 | $1.45M | Buy |
18,278
+11,349
| +164% | +$889K | 0.72% | 49 |
|
|
2020
Q2 | $511K | Buy |
6,929
+1,219
| +21% | +$91.8K | 0.26% | 64 |
|
|
2020
Q1 | $419K | Sell |
5,710
-29,796
| -84% | -$2.34M | 0.28% | 44 |
|
|
2019
Q4 | $3.08M | Buy |
35,506
+4,757
| +15% | +$391K | 1.57% | 24 |
|
|
2019
Q3 | $2.47M | Sell |
30,749
-453
| -1% | -$36.3K | 1.27% | 36 |
|
|
2019
Q2 | $2.5M | Sell |
31,202
-17,025
| -35% | -$1.3M | 1.27% | 33 |
|
|
2019
Q1 | $3.83M | Sell |
48,227
-730
| -1% | -$54.6K | 1.97% | 19 |
|
|
2018
Q4 | $3.57M | Buy |
48,957
+42,739
| +687% | +$3.02M | 2.13% | 15 |
|
|
2018
Q3 | $420K | Buy |
6,218
+799
| +15% | +$50.9K | 0.22% | 66 |
|
|
2018
Q2 | $313K | Buy |
5,419
+95
| +2% | +$5.36K | 0.17% | 67 |
|
|
2018
Q1 | $276K | Buy |
+5,324
| New | +$288K | 0.14% | 69 |
|
Other funds holding MRK
VCM
VPM
Chase Investment Counsel's MRK Position: Q1 2026 in Review
Chase Investment Counsel increased its Merck (MRK) stake by 31% in Q1 2026, buying an estimated $168K and bringing the position to 6,224 shares worth $748K. The position accounts for 0.2% of the portfolio, ranked #93.
Chase Investment Counsel first reported a position in MRK in Q1 2018 and has held it in 33 quarters since. The position peaked at $3.83M in Q1 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Chase Investment Counsel held 6,224 shares of Merck worth $748K as of Q1 2026.
- Chase Investment Counsel bought 1,456 Merck shares in Q1 2026, an estimated $168K.
- Merck made up 0.2% of Chase Investment Counsel's portfolio in Q1 2026, its #93 holding.
- Chase Investment Counsel first reported a position in Merck in Q1 2018 and has held it in 33 quarters since.
- Chase Investment Counsel's Merck position peaked at $3.83M in Q1 2019.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Chase Investment Counsel's 13F filing for Q1 2026, filed 12 May 2026.